Interactions of taurine and beta-alanine with central nervous system neurotransmitter receptors.
D000409:Alanine / Q000494:pharmacology*; D000818:Animals; D001667:Binding, Competitive; D001921:Brain / Q000187:drug effects*; D003975:Diazepam / Q000378:metabolism; D004082:Dihydroalprenolol / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D008297:Male; D008566:Membranes / Q000187:drug effects; D009118:Muscimol / Q000378:metabolism; D010870:Pineal Gland / Q000187:drug effects; D011869:Radioligand Assay; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects*; D011950:Receptors, Cholinergic / Q000187:drug effects*; D013654:Taurine / Q000494:pharmacology*; D015091:beta-Alanine / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D011941:Receptors, Adrenergic; D011943:Receptors, Adrenergic, beta; D011950:Receptors, Cholinergic; D015091:beta-Alanine; D013654:Taurine; D009118:Muscimol; D005680:gamma-Aminobutyric Acid; D004082:Dihydroalprenolol; D000409:Alanine; D003975:Diazepam